In a search for new proteins involved in the progression of Alzheimer's disease, Philippe Marambaud, PhD, an investigator in the Litwin-Zucker Research Center for the Study of Alzheimer's Disease at the Feinstein Institute, discovered the protein calcium homeostasis modulator 1 (CALHM1) in 2008. CALHM1 represents a new family of pore-forming membrane proteins involved in the control of the levels of amyloid-beta peptide, a main trigger for Alzheimer's disease.
After additional studies in a mouse that did not have the CALHM1 gene, Dr. Marambaud and his lab found that the mouse had severely impaired perceptions of sweet, bitter and umami (a savory taste that is abundant in fish, shellfish, cured meats, mushrooms, and vegetables) tastes. This indicated that CALHM1 is of paramount importance for the integrity of the sense of taste.
"While studying the role of CALHM1 in the context of Alzheimer's disease, we realized that this protein also plays a fundamental role in normal physiology, that is taste perception," said Dr. Marambaud. "This finding is exciting because it unravels the mechanism of communication to the brain during taste perception. The connection between Alzheimer's disease and taste is unclear at this point, but this study might motivate some investigation in this field."
About the Litwin-Zucker Research Center for the Study of Alzheimer's Disease
The Litwin-Zucker Research Center is part of the Feinstein Institute for Medical Research. Researchers who work in the lab have been studying Alzheimer's disease in an effort of identifying new treatments and diagnostics for this devastating disorder of the brain.
About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer's disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information visit www.FeinsteinInstitute.org.
Bioenergy cropland expansion could be as bad for biodiversity as climate change
11.12.2018 | Senckenberg Forschungsinstitut und Naturmuseen
How glial cells develop in the brain from neural precursor cells
11.12.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals
Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.
Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.
Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...
10.12.2018 | Event News
06.12.2018 | Event News
03.12.2018 | Event News
11.12.2018 | Physics and Astronomy
11.12.2018 | Materials Sciences
11.12.2018 | Information Technology